(Q39906654)

15 September 2017

title

N(G)-acylated aminothiazolylpropylguanidines as potent and selective histamine H(2) receptor agonists (English)

1 reference

15 September 2017

Anja Kraus

1

1 reference

15 September 2017

Prasanta Ghorai

2

1 reference

15 September 2017

Tobias Birnkammer

3

1 reference

15 September 2017

David Schnell

4

1 reference

15 September 2017

Sigurd Elz

5

1 reference

15 September 2017

Roland Seifert

6

1 reference

15 September 2017

Stefan Dove

7

1 reference

15 September 2017

Günther Bernhardt

8

1 reference

15 September 2017

Armin Buschauer

9

1 reference

15 September 2017

publication date

1 February 2009

1 reference

15 September 2017

1 reference

15 September 2017

volume

4

1 reference

15 September 2017

issue

2

1 reference

15 September 2017

page(s)

232-240

1 reference

Structure-activity relationships of histamine H2 receptor ligands

15 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200800296

Histamine H2-receptor agonists. Synthesis, in vitro pharmacology, and qualitative structure-activity relationships of substituted 4- and 5-(2-aminoethyl)thiazoles

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200800296

7 January 2021

The new potent and selective histamine H2 receptor agonist amthamine as a tool to study gastric secretion

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200800296

7 January 2021

In vitro cardiac pharmacology of the new histamine H2-receptor agonist amthamine: comparisons with histamine and dimaprit

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200800296

7 January 2021

Evaluation of histamine H1-, H2-, and H3-receptor ligands at the human histamine H4 receptor: identification of 4-methylhistamine as the first potent and selective H4 receptor agonist

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200800296

7 January 2021

Potential histamine H2-receptor antagonists. 3. Methylhistamines

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200800296

7 January 2021

Chemical differentiation of histamine H1- and H2-receptor agonists

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200800296

7 January 2021

A one-pot process for the enantioselective synthesis of amines via reductive amination under transfer hydrogenation conditions

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200800296

7 January 2021

Definition and antagonism of histamine H 2 -receptors

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200800296

7 January 2021

Distinct interaction of human and guinea pig histamine H2-receptor with guanidine-type agonists.

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200800296

7 January 2021

Synthesis and in vitro pharmacology of arpromidine and related phenyl(pyridylalkyl)guanidines, a potential new class of positive inotropic drugs

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200800296

7 January 2021

Probing ligand-specific histamine H1- and H2-receptor conformations with NG-acylated Imidazolylpropylguanidines

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200800296

7 January 2021

N1-(3-cyclohexylbutanoyl)-N2-[3-(1H-imidazol-4-yl)propyl]guanidine (UR-AK57), a potent partial agonist for the human histamine H1- and H2-receptors

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200800296

7 January 2021

High-resolution crystal structure of an engineered human beta2-adrenergic G protein-coupled receptor

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200800296

7 January 2021

GPCR engineering yields high-resolution structural insights into beta2-adrenergic receptor function

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200800296

7 January 2021

The agonistic binding site at the histamine H2 receptor. II. Theoretical investigations of histamine binding to receptor models of the seven alpha-helical transmembrane domain

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200800296

7 January 2021

Pharmacological profile of histaprodifens at four recombinant histamine H1 receptor species isoforms

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200800296

7 January 2021

A pH-dependent model of the activation mechanism of the histamine H2 receptor

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200800296

7 January 2021

Development and testing of a general amber force field

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200800296

7 January 2021

Identifiers

DOI

10.1002/CMDC.200800296

1 reference

15 September 2017

1 reference